BioMed Know-how Holdings Restricted, a startup nurtured by Hong Kong Science Park, was based by a gaggle of CUHK professors and alumni. The corporate focuses on microbiology and bioinformatics and is devoted to selling exact and personalised microbiome-based interventions. These interventions are designed to revive the stability of the oral, pores and skin, and intestine microbiomes, thereby enhancing each bodily and psychological well being.
So far, BioMed has efficiently constructed a microbiome database comprising over 10,000 information factors gathered from numerous areas throughout Asia. This invaluable database continues to develop and serves as a promising cornerstone for the corporate’s future R&D endeavors.
Commercially, BioMed has established collaborations with over 200 healthcare service suppliers in Hong Kong and instantly markets its merchandise like E3 probiotics and EC Cream to shoppers by greater than 260 stores beneath the PGut Model. Moreover, the corporate has additionally expanded its operations to Macau, Mainland China, and Thailand.
Managing Director and Chief Funding Officer of CUHK Innovation Restricted, Ms Joyce Ng, ” Persons are important constructing blocks for enterprise success. The founders of this firm comprise professionals from numerous fields who’ve robust ties to CUHK. These embody Professor Tsui Kwok-Wing Stephen, a professor within the College of Biomedical Sciences and director of the Hong Kong Bioinformatics Centre and the Centre for Microbial Genomics and Proteomics at CUHK, Dr. Steven Bathroom, a dermatologist and Medical Assistant Professor (honorary) at CUHK, and Vincent Tsang, a serial entrepreneur and CUHK alumnus. By combining their experience, we consider they will drive innovation and commercialisation to ship subsequent technology of customerized options to shoppers.”
Medical director and co-founder of BioMed, Dr. Steven Bathroom acknowledged, “We’re honored to be the primary firm to obtain funding from the newly established CUHK Innovation Restricted. This partnership will present us with invaluable help and entry to CUHK’s strong ecosystem, enabling us to speed up our analysis and growth initiatives and increase our market presence. With the backing of the CUHK Innovation Restricted, we’re assured in our potential to take BioMed to new heights of innovation and empower people with personalised and efficient healthcare options that harness the potential of the microbiome.”
As a part of its strategic growth, BioMed has not too long ago launched a pioneering initiative within the quickly rising pet healthcare market. It has joined forces with PetSpace, the main veterinary group in Hong Kong, to conduct a large-scale analysis venture recruiting a complete of 500 felines and canines. This collaboration has positioned BioMed as the first repository of pet microbiome information in Hong Kong. BioMed and PSG Vivet, a veterinarian-led product growth firm, have shaped a strategic partnership to develop intestine microbiome exams and personalised probiotics for pets. The merchandise are anticipated to launch in Q3 2024.
Chief Government Officer and co-founder of BioMed, Mr. Vincent Tsang stated,”By means of the help of the CUHK Innovation Restricted, BioMed has fortified its capabilities in offering microbiome-based options for human and veterinary healthcare. Our unwavering dedication to superior expertise, scientific analysis, and personalised well being administration positions us with utmost confidence to drive innovation and ship distinctive outcomes.”
Hashtag: #BioMedTechnology #BioMed #SciencePark #microbiome #probiotics #CUHKInnovation
https://biomed.hk/
https://www.fb.com/PGUT.HK/
The issuer is solely answerable for the content material of this announcement.
About BioMed Know-how Holdings Restricted
BioMed Know-how Holdings Restricted (BioMed), a startup nurtured by Hong Kong Science Park, was based by a gaggle of CUHK professors and alumni. It advocates exact and personalised microbiome-based healthcare options based mostly on DNA testing outcomes, to revive the stability of oral, pores and skin and intestine microbiome.
BioMed has raised funds in its oversubscribed seed spherical from Alibaba Hong Kong Entrepreneurs Fund (AEF), Gobi Companions GBA, The Worldwide Medical Co. Ltd. (TIMC) and Human Well being Holdings Restricted (1419.HK). DSS (NYEX: DSS), a US listed firm can be a shareholder of BioMed.
https://biomed.hk/
About CUHK Innovation Restricted
CUHK Innovation Restricted is a newly established firm wholly owned by CUHK to make investments in modern enterprise and affect ventures associated to CUHK’s technological improvements. CUHK Innovation Restricted will begin with an early-stage fund, with a concentrate on looking for matching funds from enterprise capital buyers.
The Firm is dedicated to supporting CUHK’s spin-off firms as they commercialise their modern analysis and growth achievements, and furthering the College’s mission in selling and enhancing entrepreneurial tradition.
https://cuhkinnovation.hk/